Display options
Cite
James AJ, Smith CC, Litzow M, et al. Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor. Clin Pharmacokinet. 2021;60(9):1251doi: 10.1007/s40262-021-01060-8.
James, A. J., Smith, C. C., Litzow, M., Perl, A. E., Altman, J. K., Shepard, D., Kadokura, T., Souda, K., Patton, M., Lu, Z., Liu, C., Moy, S., Levis, M. J., & Bahceci, E. (2021). Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor. Clinical pharmacokinetics, 60(9), 1251. https://doi.org/10.1007/s40262-021-01060-8
James, Angela Joubert, et al. "Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor." Clinical pharmacokinetics vol. 60,9 (2021): 1251. doi: https://doi.org/10.1007/s40262-021-01060-8
James AJ, Smith CC, Litzow M, Perl AE, Altman JK, Shepard D, Kadokura T, Souda K, Patton M, Lu Z, Liu C, Moy S, Levis MJ, Bahceci E. Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor. Clin Pharmacokinet. 2021 Sep;60(9):1251. doi: 10.1007/s40262-021-01060-8. PMID: 34297319; PMCID: PMC8416867.
Copy Download .nbib Format: NLM
Share it on

Clin Pharmacokinet. 2021 Sep;60(9):1251. doi: 10.1007/s40262-021-01060-8.

Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor.

Clinical pharmacokinetics

Angela Joubert James, Catherine C Smith, Mark Litzow, Alexander E Perl, Jessica K Altman, Dale Shepard, Takeshi Kadokura, Kinya Souda, Melanie Patton, Zheng Lu, Chaofeng Liu, Selina Moy, Mark J Levis, Erkut Bahceci

Affiliations

  1. Astellas Pharma US, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA. [email protected].
  2. University of California San Francisco, San Francisco, CA, USA.
  3. Mayo Clinic, Rochester, NY, USA.
  4. University of Pennsylvania-Abramson Comprehensive Cancer Center, Philadelphia, PA, USA.
  5. Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.
  6. Cleveland Clinic, Cleveland, OH, USA.
  7. Astellas Pharma, Inc., Tokyo, Japan.
  8. Astellas Pharma US, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA.
  9. John Hopkins University, Baltimore, MD, USA.

PMID: 34297319 PMCID: PMC8416867 DOI: 10.1007/s40262-021-01060-8

[No abstract available.]

Publication Types